1. Introduction {#s0005}
===============

Major depressive disorder (MDD) and dysthymia are two common psychiatric disorders where the clinical presentation is typically dominated by a dysphoric mood. While MDD is typically episodic, and durations can be as short as two weeks, dysthymia is a form of chronic depression characterized by depressed mood more days than not, and symptoms that last two years or more. Dysthymic patients tend to have a fluctuating course ([@bb0005]) and often have a superimposed episode of MDD, a phenomenon called double depression (DD) ([@bb0035]). Dysthymia affects approximately 3% of the adult population ([@bb0105]) and has a prevalence of about 36% of outpatients in mental health settings ([@bb0075]).

The relationship between dysthymia and MDD is complex. The two conditions are highly comorbid ([@bb0075; @bb0105]) and it remains unclear whether the two conditions reflect two separate disease entities or different aspects of a single condition ([@bb0015; @bb0040; @bb0095]). Some distinctions have been made: dysthymia and DD differ from MDD in that they have poorer outcomes in naturalistic follow-up studies ([@bb0065]), greater Axes I and II comorbidity ([@bb0075]) and are more likely to have a family history of mood and personality disorders ([@bb0055; @bb0060; @bb0090]). Few studies have systematically examined, in European populations, differences in patients with recurrent MDD without a history of dysthymia and DD.

In this report, we examine a large sample of carefully assessed Han Chinese women with recurrent major depression, to determine if the clinical course and pattern of comorbidity differ in those with and without a history of dysthymia. To our knowledge, this is the first time these questions have been addressed in data from an East Asian population. Compared to women with recurrent MDD without a history of dysthymia, we expected DD patients to exhibit a higher level of depressive symptomatology, an earlier onset of depression, higher rates of familial aggregation and greater comorbidity especially with anxiety disorders ([@bb0030; @bb0100]).

2. Methods {#s0010}
==========

2.1. Subjects {#s0015}
-------------

Data for the present study draws upon the ongoing China, Oxford and VCU Experimental Research on Genetic Epidemiology (CONVERGE) study of MDD. These analyses were based on a total of 1970 cases recruited from 53 provincial mental health centers and psychiatric departments of general medical hospitals in 41 cities in 19 provinces and four central cities: Beijing, Shanghai, Tianjin and Chongqing and 2597 controls who were recruited from patients undergoing minor surgical procedures at general hospitals or from local community centers. All cases and controls were female and had four Han Chinese grandparents. Cases and controls were excluded if they had a pre-existing history of bipolar disorder, any type of psychosis or mental retardation. Cases were aged between 30 and 60, had two or more episodes of MDD, with the first episode occurring between 14 and 50 and had not abused drug or alcohol before the first episode of MDD. Controls were chosen to match the region of origin of cases, were aged between 40 and 60, had never experienced an episode of MDD and were not blood relatives of cases. An older minimal age of controls was used to reduce the chances that they might have a subsequent first onset of MDD. The mean age (and SD) of cases and controls in the dataset was respectively 45.1 (8.8) and 47.7 (5.5).

All subjects were interviewed using a computerized assessment system, which lasted on average two hours for a case and one hour for a control. All interviewers were trained by the CONVERGE team for a minimum of one week in the use of the interview. The interview includes assessment of psychopathology, demographic and personal characteristics, and psychosocial functioning. Interviews were tape-recorded and a proportion of them were listened to by the trained editors who provided feedback on the quality of the interviews. The study protocol was approved centrally by the Ethical Review Board of Oxford University and the ethics committee in participating hospitals in China.

2.2. Measures {#s0020}
-------------

The diagnoses of depressive (Dysthymia and Major Depressive Disorder) and anxiety disorders (Generalized Anxiety Disorder, Panic Disorder with or without Agoraphobia) were established with the Composite International Diagnostic Interview (CIDI) (WHO lifetime version 2.1; Chinese version), which classifies diagnoses according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria ([@bb0010]).

The interview was originally translated into Mandarin by a team of psychiatrists in Shanghai Mental Health Centre with the translation reviewed and modified by members of the CONVERGE team. Phobias, divided into five subtypes (animal, situational, social and blood-injury, and agoraphobia) were diagnosed using an adaptation of DSM-III criteria requiring one or more unreasonable fears, including fears of different animals, social phobia and agoraphobia that objectively interfered with the respondent\'s life. The section on the assessment of phobias was translated by the CONVERGE team from the interview used in the Virginia Adult Twin Study of Psychiatric and Substance Use Disorders (VATSPUD) ([@bb0045]).

Additional information was collected using instruments employed from VATSPSUD, translated and reviewed for accuracy by members of the CONVERGE team. The history of lifetime major depression in the parents and siblings was assessed using the Family History Research Diagnostic criteria ([@bb0020]). The stressful life events section, also developed for the VATSPSUD study, assessed 16 traumatic lifetime events and the age at their occurrence. Neuroticism was measured with the 23-item Eysenck Personality Questionnaire ([@bb0025]), which was also an established instrument for measuring neuroticism.

Both the case and control interviews were fully computerized into a bilingual system of Mandarin and English developed in house in Oxford, and called SysQ. Skip patterns were built into SysQ. Interviews were administered by trained interviewers and entered offline in real time onto SysQ, which was installed in the laptops. Once an interview was completed, a backup file containing all the previously entered interview data could be generated with database compatible format. The backup file, together with an audio recording of the entire interview, was uploaded to a designated server currently maintained in Beijing by a service provider. All the uploaded files in the Beijing server were then transferred to an Oxford server quarterly.

2.3. Statistical analysis {#s0025}
-------------------------

Statistical analyses were performed using the software package SPSS 17.0 (SPSS Inc., Chicago, IL). We performed logistic regression analyses to estimate the association of dysthymia with MDD and comorbid disorders. Linear and logistic regression models were used to determine the association of between measures. Coefficient values, odds ratios and 95% confidence intervals were used to quantify the strength of associations. The statistical significance for all tests was set at P \< 0.05 and corrected where necessary for multiple testing using a Bonferroni correction.

3. Results {#s0030}
==========

3.1. Sample characteristics {#s0035}
---------------------------

From our total of 1970 cases with recurrent MDD, 354 met criteria for dysthymia. Comparing those with and without a diagnosis of dysthymia, we found no significant difference in age at interview, marital status or level of education. We then examined the two groups for differences in the onset and course of MDD and other potentially important risk factors, especially personality and family history.

As seen in [Table 1](#t0005){ref-type="table"}, patients with dysthymia had a significantly earlier age of onset of MDD, more depressive episodes and a significantly longer "longest episode" compared to MDD patients without a history of dysthymia. Dysthmic patients had significantly higher levels of neuroticism, reported a significantly greater number of stressful life events and were likely to have one or more first-degree family members with a history of MDD.

3.2. Comorbidity {#s0040}
----------------

We compared lifetime prevalence rates of 6 anxiety disorders in MDD patients with and without dysthymia ([Table 2](#t0010){ref-type="table"}). MDD patients with a history of dysthymia have significantly higher rates of panic disorder, GAD and agoraphobia, social and blood injury phobias, and animal and situational phobias (the P-value for animal phobias remains significant after applying a Bonferroni correction for testing nine measures (corrected threshold is P = 0.0056)). We also observed significantly higher rates of post-natal depression in the dysthymic patients. However there was no significant difference in the rates of melancholia between the two groups.

4. Discussion {#s0045}
=============

Our study addresses an issue concerning the nosology of mood disorders in a large carefully characterized cohort of Han Chinese women with major depression. We investigated the extent to which patients with recurrent MDD with dysthymia could be distinguished from those with recurrent MDD without comorbid dysthymia. We uncovered a number of important differences between these two groups, suggesting that the additional diagnosis of dysthymia in cases of recurrent MDD defines a meaningful and potentially important subtype.

Our major findings are that the cases with dysthymia have a more severe MDD, as indexed by both the number and length of episodes. They had greater co-morbidity with anxiety disorders, higher neuroticism scores and a stronger familial loading for MDD. They had experienced greater environmental adversity as indicated by the number of reported serious life events.

These results are broadly consistent with what has been seen in Western studies contrasting MDD patients with and without dysthymia and showing the former to have greater comorbidity ([@bb0075]) and increased rates of a family history of MDD ([@bb0055; @bb0060; @bb0090]).

How can we explain the differences we observe between our cases of recurrent MDD with and without dysthymia? The distinguishing features are a mixture that does not easily fall into neat categories. The greater severity of illness and higher familial/genetic loading might suggest a more biological disorder ([@bb0030; @bb0100]). However, no excess rates of melancholia were seen in our DD cases, arguing against a more "biological/endogenous" picture. Furthermore, the presence of dysthymia was associated with evidence for greater environmental adversity. The picture of high levels of neuroticism and high comorbidity with anxiety disorders could be interpreted as a more "neurotic" depressive picture, consistent with the origin of dysthymia in DSM-III with the alternative title of "depressive neurosis." Further studies will be needed to examine more closely the etiologic relationship between MDD cases with and without a history of dysthymia.

Our study benefits from considering the literature on cross-culture variation in dysthymia. A series of large community-based studies conducted in several countries by the World Health Organization shows substantially higher estimates for dysthymia in high-income countries than in low and middle-income countries ([@bb0050]). Furthermore, the same studies reveal variation in severity: whereas 21% of patients were rated as "severe" in Germany, 46% of patients in China and 59% of patients in Nigeria were so rated. However, wherever it occurs dysthymia confers a substantial risk of suicide ([@bb0080]) and considerable impairment in functioning ([@bb0050]).

Part of the cross cultural variation in dysthymia can be attributed to the different way depressive symptoms are presented to clinicians, for instance in China somatizing psychological stress via constructs such as neurasthenia ([@bb0070]). However it should be noted that, as [@bb0085] argue, diagnostic rates will vary if more flexible, but still rigorous, structured interviews are used. For example, in a survey of 12% of the adult population of China, only 15 of 16,577 individuals who completed the Structured Clinical Interview for Diagnostic and Statistical Manual (DSM)-IV axis I disorders met research criteria for neurasthenia, while dysthymia emerged as the second most common specific mood disorder ([@bb0085]).

Our results should be considered in the context of several limitations. First, all of the patients were from in-patient hospital samples so that our findings are not representative of community samples (which are likely to include less severely ill patients). Second, our data were collected retrospectively and recall bias will have affected results. Finally, all patients were female, so the applicability of our results to male patients is unknown.
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###### 

Relationship between six clinical features of major depressive disorder and dysthymia.

  Clinical feature of MDD       P-value     OR     95% CI
  ----------------------------- ----------- ------ ------------
  Age of onset                  \< 0.0001   0.96   0.94--0.97
  Duration of longest episode   \< 0.0001   1.04   1.01--1.05
  Number of episodes of MD      \< 0.0001   1.03   1.02--1.03
  SLE (number of episodes)      \< 0.0001   1.24   1.16--1.33
  Family history of MD          0.0002      1.27   1.12--1.45
  Neuroticism                   \< 0.0001   1.12   1.09--1.15

MDD: Major depressive disorder. SLE: Stressful life events. OR: Odds ratio. 95% CI: 95% Confidence intervals.

###### 

The relationship between dysthymia and nine disorders comorbid with major depressive disorder.

  Comorbid disorder      P-value     OR     95% CI
  ---------------------- ----------- ------ ------------
  Agoraphobia            \< 0.0001   1.48   1.28--1.70
  Social phobia          \< 0.0001   1.46   1.28--1.67
  Animal phobia          0.0027      1.14   1.05--1.24
  Situational phobia     \< 0.0001   1.36   1.23--1.51
  Blood phobia           \< 0.0001   1.32   1.17--1.48
  GAD                    \< 0.0001   1.87   1.47--2.38
  Melancholia            0.64        0.93   0.69--1.25
  Postnatal depression   \< 0.0001   2.05   1.56--2.70
  Panic                  \< 0.0001   2.71   1.96--3.74

GAD: Generalized anxiety disorder. OR: Odds ratio. 95% CI: 95% Confidence intervals.
